BECTON DICKINSON & CO — Director's Dealing 2019

Aug 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2019-08-08

Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-08	Common Stock	M	2865	$224.94	Acquired	19072	Direct
2019-08-08	Common Stock	D	2615	$246.56	Disposed	16457	Direct
2019-08-08	Common Stock	S	250	$246.56	Disposed	16207	Direct
2019-08-08	Common Stock	S	150	$246.53	Disposed	16057	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-08	Stock Appreciation Rights	$224.94	M	2865	Disposed	2028-06-01	Common Stock (2865)	Direct

Footnotes

F1: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $246.53 through $246.86. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.

F2: The stock appreciation rights vest in four annual installments beginning June 1, 2019.